- Home
- DAWN vs YRD Comparison
DAWN vs YRD Comparison
Compare DAWN & YRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- YRD
- Stock Information
- Founded
- DAWN 2018
- YRD 2012
- Country
- DAWN United States
- YRD China
- Employees
- DAWN N/A
- YRD N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- YRD Finance: Consumer Services
- Sector
- DAWN Health Care
- YRD Finance
- Exchange
- DAWN Nasdaq
- YRD Nasdaq
- Market Cap
- DAWN 624.8M
- YRD 532.3M
- IPO Year
- DAWN 2021
- YRD 2015
- Fundamental
- Price
- DAWN $7.47
- YRD $5.78
- Analyst Decision
- DAWN Strong Buy
- YRD
- Analyst Count
- DAWN 7
- YRD 0
- Target Price
- DAWN $27.86
- YRD N/A
- AVG Volume (30 Days)
- DAWN 1.5M
- YRD 87.0K
- Earning Date
- DAWN 10-30-2025
- YRD 11-19-2025
- Dividend Yield
- DAWN N/A
- YRD 7.60%
- EPS Growth
- DAWN N/A
- YRD N/A
- EPS
- DAWN N/A
- YRD 2.07
- Revenue
- DAWN $187,638,000.00
- YRD $856,794,857.00
- Revenue This Year
- DAWN $12.96
- YRD N/A
- Revenue Next Year
- DAWN $48.40
- YRD N/A
- P/E Ratio
- DAWN N/A
- YRD $2.89
- Revenue Growth
- DAWN 2190.50
- YRD 12.42
- 52 Week Low
- DAWN $5.64
- YRD $4.41
- 52 Week High
- DAWN $16.76
- YRD $8.74
- Technical
- Relative Strength Index (RSI)
- DAWN 53.82
- YRD 42.47
- Support Level
- DAWN $6.99
- YRD $5.85
- Resistance Level
- DAWN $7.73
- YRD $6.79
- Average True Range (ATR)
- DAWN 0.44
- YRD 0.23
- MACD
- DAWN 0.02
- YRD -0.04
- Stochastic Oscillator
- DAWN 48.73
- YRD 1.92
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About YRD Yiren Digital Ltd.
Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.